Tuesday, November 03, 2015 12:06:20 PM
The NIH announcement I believe lays the ground work for expanded access here in the US. It's difficult to know what form it will take, --- one could hope for the 17 experts wish, but I don't know. I imagine some sort of trial, using a sub-group, hopefully the NK Cell marker. the FDA wants more data, and they'll have to get it somehow. Who pays?...is my question - Hemispherx cannot afford to go it alone. Hopefully this is part of the NIH plan. The new NINDS (division ME/CFS is now in) director says they are going to move fairly quickly. My guess, end of this year or beginning of next for any ampligen news. Maybe we'll get a nice surprise for Christmas.
Other than that, I imagine we'll here about MERS orphan status from the EU soon.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM